发明名称 Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
摘要 Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes from the body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is the primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism (familial combined hyperlipemia (FCHL), postprandial hyperlipidemia, hypertriglyceridemia with low levels of HDL cholesterol, and insulin resistance associated with type-II diabetes and obesity), is ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. Based on this new insight, novel preventive measures and treatment modalities of disturbed lipid metabolism are introduced.
申请公布号 US7498147(B2) 申请公布日期 2009.03.03
申请号 US20020327604 申请日期 2002.12.20
申请人 CROSSBETA BIOSCIENCES B.V. 发明人 CABEZAS MANUEL CASTRO;VAN DIJK HANS
分类号 A23L1/30;C12Q1/02;A23L1/29;A23L1/305;A61K31/454;A61K38/00;A61K38/17;A61K38/39;A61K38/46;A61K38/48;A61K39/39;A61K39/395;A61K45/00;A61K47/44;A61K48/00;A61P3/00;A61P3/06;A61P7/00;A61P9/10;A61P29/00;A61P31/00;A61P35/00;A61P37/00;A61P37/06;A61P43/00;G01N33/564;G01N33/566;G01N33/573;G01N33/92 主分类号 A23L1/30
代理机构 代理人
主权项
地址